[go: up one dir, main page]

AR005969A1 - Procedimiento para preparar composiciones farmaceuticas que contienen benzotiofenos como agente activo, en unidades dosificadas o formulaciones de dosis multiple - Google Patents

Procedimiento para preparar composiciones farmaceuticas que contienen benzotiofenos como agente activo, en unidades dosificadas o formulaciones de dosis multiple

Info

Publication number
AR005969A1
AR005969A1 ARP970100726A ARP970100726A AR005969A1 AR 005969 A1 AR005969 A1 AR 005969A1 AR P970100726 A ARP970100726 A AR P970100726A AR P970100726 A ARP970100726 A AR P970100726A AR 005969 A1 AR005969 A1 AR 005969A1
Authority
AR
Argentina
Prior art keywords
pharmaceutical compositions
compositions containing
multiple dose
procedure
preparing pharmaceutical
Prior art date
Application number
ARP970100726A
Other languages
English (en)
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GBGB9604912.7A external-priority patent/GB9604912D0/en
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of AR005969A1 publication Critical patent/AR005969A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/62—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/64—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system
    • A61P5/24—Drugs for disorders of the endocrine system of the sex hormones
    • A61P5/30—Oestrogens
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
    • C07D333/50—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom condensed with carbocyclic rings or ring systems
    • C07D333/52—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes
    • C07D333/54—Benzo[b]thiophenes; Hydrogenated benzo[b]thiophenes with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to carbon atoms of the hetero ring
    • C07D333/56—Radicals substituted by oxygen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Reproductive Health (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)

Abstract

Un procedimiento para preparar composiciones farmacéuticas que contienen benzotiofenos de fórmula (I) como agente para inhibir la osteoporosis, regularla colesterolemia y/o inhibir el cáncer estrógeno-dependiente, como formulacionesde dosis múltiple o unidades dosificadas.
ARP970100726A 1996-02-22 1997-02-21 Procedimiento para preparar composiciones farmaceuticas que contienen benzotiofenos como agente activo, en unidades dosificadas o formulaciones de dosis multiple AR005969A1 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US1204496P 1996-02-22 1996-02-22
GBGB9604912.7A GB9604912D0 (en) 1996-03-08 1996-03-08 Benzothiophenes, formulations containing same, and methods

Publications (1)

Publication Number Publication Date
AR005969A1 true AR005969A1 (es) 1999-07-21

Family

ID=26308887

Family Applications (2)

Application Number Title Priority Date Filing Date
ARP970100726A AR005969A1 (es) 1996-02-22 1997-02-21 Procedimiento para preparar composiciones farmaceuticas que contienen benzotiofenos como agente activo, en unidades dosificadas o formulaciones de dosis multiple
ARP970100727A AR005970A1 (es) 1996-02-22 1997-02-21 Compuestos de benzotiofeno y formulaciones farmaceuticas que los contienen como agente activo

Family Applications After (1)

Application Number Title Priority Date Filing Date
ARP970100727A AR005970A1 (es) 1996-02-22 1997-02-21 Compuestos de benzotiofeno y formulaciones farmaceuticas que los contienen como agente activo

Country Status (23)

Country Link
EP (1) EP0791591B1 (es)
JP (1) JP2000505455A (es)
KR (1) KR19990087091A (es)
CN (1) CN1211921A (es)
AR (2) AR005969A1 (es)
AT (1) ATE204869T1 (es)
AU (1) AU713204B2 (es)
BR (1) BR9707657A (es)
CA (1) CA2246721A1 (es)
CO (1) CO4761064A1 (es)
CZ (1) CZ260798A3 (es)
DE (1) DE69706338T2 (es)
DK (1) DK0791591T3 (es)
EA (1) EA000767B1 (es)
ES (1) ES2162196T3 (es)
IL (1) IL125863A (es)
NO (1) NO983802L (es)
NZ (1) NZ331461A (es)
PL (1) PL328832A1 (es)
PT (1) PT791591E (es)
TR (1) TR199801612T2 (es)
WO (1) WO1997030709A1 (es)
YU (1) YU6797A (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2304138A1 (en) * 1997-09-23 1999-04-01 Eli Lilly And Company Benzothiophenes
US6465445B1 (en) 1998-06-11 2002-10-15 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US7005428B1 (en) 1998-06-11 2006-02-28 Endorecherche, Inc. Medical uses of a selective estrogen receptor modulator in combination with sex steroid precursors
US6060488A (en) * 1998-09-22 2000-05-09 Eli Lilly And Company Benzothiophenes for treating estrogen deficiency
ATE274507T1 (de) * 2000-12-05 2004-09-15 Hoffmann La Roche Benzofuran- und benzothiophen-derivative als selektive cox-2 inhibitoren
EP1782810A3 (en) * 2002-07-22 2007-05-23 Eli Lilly & Company Selective estrogen receptor modulators containing a phenylsulfonyl group
BR0312675A (pt) * 2002-07-22 2005-05-03 Lilly Co Eli Composto ou um sal de adição de ácido farmacêutico do mesmo,m e, métodos para tratar endometriose, e para tratar leiomioma uterino
CA2499819A1 (en) 2002-09-30 2004-04-08 A/S Gea Farmaceutisk Fabrik Novel raloxifene acid addition salts and/or solvates thereof, improved method for purification of said raloxifene acid addition salts and/or solvates thereof and pharmaceutical compositions comprising these
NZ541126A (en) * 2003-02-25 2008-07-31 Lilly Co Eli Crystalline non-solvated 1-(4-(2-piperidinylethoxy)phenoxy)-2-(4-methanesulfonylphenyl)-6-hydroxynaphthalene hydrochloride
EP1713770A1 (en) * 2004-01-29 2006-10-25 Eli Lilly And Company Selective estrogen receptor modulators
GR1005694B (el) * 2005-06-08 2007-10-22 Αλεξης Μιχαηλ Ιστοειδικα αντιοιστρογονα ειδικα για τον αλφα υποδοχεα των οιστρογονων
CN111018770A (zh) * 2019-12-26 2020-04-17 北京鑫开元医药科技有限公司 一种巴多昔芬氧化物的制备方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ200204A (en) * 1981-04-03 1985-05-31 Lilly Co Eli Benzothiophene derivatives and process for preparation
US5482949A (en) * 1993-03-19 1996-01-09 Eli Lilly And Company Sulfonate derivatives of 3-aroylbenzo[b]thiophenes
US6756388B1 (en) * 1993-10-12 2004-06-29 Pfizer Inc. Benzothiophenes and related compounds as estrogen agonists
US5510357A (en) * 1995-02-28 1996-04-23 Eli Lilly And Company Benzothiophene compounds as anti-estrogenic agents

Also Published As

Publication number Publication date
EA000767B1 (ru) 2000-04-24
PL328832A1 (en) 1999-02-15
NO983802D0 (no) 1998-08-19
JP2000505455A (ja) 2000-05-09
IL125863A (en) 2000-10-31
BR9707657A (pt) 1999-07-27
IL125863A0 (en) 1999-04-11
AU713204B2 (en) 1999-11-25
TR199801612T2 (xx) 1998-11-23
EP0791591A1 (en) 1997-08-27
DK0791591T3 (da) 2001-10-08
DE69706338T2 (de) 2002-06-13
WO1997030709A1 (en) 1997-08-28
PT791591E (pt) 2001-12-28
EP0791591B1 (en) 2001-08-29
ES2162196T3 (es) 2001-12-16
DE69706338D1 (de) 2001-10-04
CA2246721A1 (en) 1997-08-28
CZ260798A3 (cs) 1999-05-12
CO4761064A1 (es) 1999-04-27
NZ331461A (en) 1999-05-28
KR19990087091A (ko) 1999-12-15
EA199800753A1 (ru) 1999-02-25
AR005970A1 (es) 1999-07-21
NO983802L (no) 1998-08-19
AU2276497A (en) 1997-09-10
CN1211921A (zh) 1999-03-24
YU6797A (sh) 1999-09-27
ATE204869T1 (de) 2001-09-15

Similar Documents

Publication Publication Date Title
AR005969A1 (es) Procedimiento para preparar composiciones farmaceuticas que contienen benzotiofenos como agente activo, en unidades dosificadas o formulaciones de dosis multiple
AR012172A2 (es) Composiciones farmaceuticas que comprenden analogos de lactacistina y uso de los mismos para la fabricacion de un medicamento
SV2002000250A (es) Formula de dosis de droga accionada por hidrogel ref. pc10818ajtb/bb
ES2052603T3 (es) Derivados de bencimidazol, procedimiento para su produccion y composicion farmaceutica que los contienen.
BR0008590A (pt) Agente de entrega polimérico, composição, formade unidade de dosagem, método para administrarum agente biologicamente ativo a um animalnecessitando o agente, método para preparar umacomposição; e composto
GT198900008A (es) Derivados de quinolina, quinazolina y cinolina.
ATE269056T1 (de) Hochwirksame dihydroergotaminhaltige arzneizusammensetzungen
ES2156840T1 (es) Medicamento que contiene polisulfato de pentosano e implante para tratar la fibrosis.
BR9911482A (pt) Composto, composição farmacêutica, uso do composto, e, processos para o tratamento ou profilaxia de doenças inflamatórias, e para a preparação de um composto
MX9202328A (es) Composicion farmaceutica local que contiene un compuesto alilamina como el agente activo.
ES2101330T3 (es) Composicion farmaceutica para uso topico que contiene un polimero cationico reticulado y un eter alcoxilado.
BR0110767A (pt) Derivados de piperidina farmaceuticamente ativos, em particular como moduladores da atividade de receptor de quimiocina
BRPI0412211A (pt) composições de liberação controlada
ES2158988T3 (es) Composiciones de aerosol.
ES2174517T3 (es) Composiciones cosmeticas con dibenciliden sorbitol y siliconas funcionalizadas.
HN2004000232A (es) " derivados de pirrolo(3,4-c) pirazol activos como inhibidores de quinasa, proceso para su preparacion y composiciones farmaceuticas que los comprenden."
ES2116642T3 (es) Composicion farmaceutica para tratar la osteoporosis que contiene xantohumol.
ES2129691T3 (es) Composicion farmaceutica para tratar la osteoporosis.
AR059723A2 (es) Composicion de altas dosis de ibandronato
ES2132101T3 (es) Procedimiento para la preparacion de un medicamento destinado a la administracion por via oral o topica en el tratamiento de leishmaniasis.
DK1392328T3 (da) Medikament til beskyttelse i radioterapi
UY28271A1 (es) Compuestos químicos
DE60019334D1 (de) Antivirale arznei
UY28366A1 (es) Compuestos químicos
BR0109672A (pt) Uso de zd6126 ou de um seu sal farmaceuticamente aceitável e um de: um agente antitumoral de plantina e um taxano, composição farmacêutica, produto de combinação, kit, e, método para a produção de um efeito de danificação vascular em um animal de sangue quente